首页> 美国卫生研究院文献>other >Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents
【2h】

Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents

机译:结构多样的苯并亚萜类似物的合成及其作为抗癌药的生物学评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diversely functionalized, fused aryl-alkyl ring systems hold a prominent position as well-established molecular frameworks for a variety of anti-cancer agents. The benzosuberene (6,7 fused, also referred to as dihydro-5H-benzo[7]annulene and benzocycloheptene) ring system has emerged as a valuable molecular core component for the development of inhibitors of tubulin assembly, which function as antiproliferative anti-cancer agents and, in certain cases, as vascular disrupting agents (VDAs). Both a phenolic-based analogue (known as >KGP18, compound >39) and its corresponding amine-based congener (referred to as >KGP156, compound >45), which demonstrate strong inhibition of tubulin assembly (low micromolar range) and potent cytotoxicity (picomolar range for >KGP18 and nanomolar range for >KGP156) are noteworthy examples of such benzosuberene-based compounds. In order to extend the structure-activity relationship (SAR) knowledge base related to benzosuberene anti-cancer agents, a series of eleven analogues (including >KGP18) were prepared in which the methoxylation pattern on the pendant aryl ring as well as functional group incorporation on the fused aryl ring were varied. The synthetic approach to these compounds featured a sequential Wittig olefination, reduction, Eaton's reagent-mediated cyclization strategy to achieve the core benzosuberone intermediate, and represented a higher-yielding synthesis of >KGP18 (which we prepared previously through a ring-expansion strategy). Incorporation of a fluorine or chlorine atom at the 1-position of the fused aryl ring or replacement of one of the methoxy groups with hydrogen (on the pendant aryl ring of >KGP18) led to benzosuberene analogues that were both strongly inhibitory against tubulin assembly (IC50 approximately 1.0 M) and strongly cytotoxic against selected human cancer cell lines (for example, GI50 = 5.47 nM against NCI-H460 cells with fluorobenzosuberene analogue >37). A water-soluble phosphate prodrug salt of >KGP18 (referred to as >KGP265, compound >44) and a water-soluble serinamide salt (compound >48) of >KGP156 were also synthesized and evaluated in this study.
机译:功能多样的,稠合的芳基-烷基环系统在各种抗癌剂的公认分子框架中占有重要地位。苯并亚戊烯(6,7稠合,也称为二氢-5H-苯并[7]环戊烯和苯并环庚烯)环系统已成为开发微管蛋白装配抑制剂的重要分子核心成分,微管蛋白装配抑制剂起着抗增殖抗癌的作用药物,在某些情况下,还可以作为血管分裂剂(VDA)。基于酚的类似物(称为> KGP18 ,化合物> 39 )及其相应的基于胺的同类物(称为> KGP156 ,化合物< strong> 45 ),显示出对微管蛋白装配的强烈抑制作用(低微摩尔范围)和强的细胞毒性(> KGP18 为皮摩尔范围,> KGP156 为纳摩尔范围)这种苯并sub基化合物的值得注意的例子。为了扩展与苯并sub烯抗癌剂有关的构效关系(SAR)知识库,制备了一系列十一种类似物(包括> KGP18 ),其中在芳基侧基上的甲氧基化方式以及在稠合的芳基环上的官能团结合是变化的。这些化合物的合成方法具有连续的Wittig烯化,还原,伊顿试剂介导的环化策略以实现核心苯并亚砜的中间体的特点,并且代表了> KGP18 的高产合成(我们之前通过环扩展策略)。在稠合的芳基环的1位上掺入氟或氯原子或用氢(在> KGP18 的侧基芳基环上)取代一个甲氧基,导致苯并亚戊烯类似物对微管蛋白装配具有强抑制作用(IC50约为1.0 M),对选定的人类癌细胞系具有较强的细胞毒性(例如,对于含氟苯并亚萜类似物> 37 的NCI-H460细胞,GI50 = 5.47 nM)。 > KGP18 的水溶性磷酸盐前药盐(称为> KGP265 ,化合物> 44 )和水溶性的丝氨酰胺盐(化合物在本研究中还合成并评估了<48> KGP156 中的> 48

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号